UBE2S Antikörper (N-Term)
Kurzübersicht für UBE2S Antikörper (N-Term) (ABIN357497)
Target
Alle UBE2S Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- This antibody is specific to UBE2S/E2EPF (N-term). Predicted to cross react with Mouse (100 % Antigen Homology).
-
Aufreinigung
- Protein G Chromatography, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
-
Immunogen
- This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the N-terminal region of human E2EPF.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
-
ELISA: 1/1,000. Western Blot: 1/100-1/500. Immunohistochemistry: 1/50-1/100.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) Sodium Azide as preservative.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at-20 °C for longer.
-
-
- UBE2S (Ubiquitin-Conjugating Enzyme E2S (UBE2S))
-
Andere Bezeichnung
- UBE2S
-
Hintergrund
- This gene encodes a member of the ubiquitin-conjugating enzyme family. The encoded protein is able to form a thiol ester linkage with ubiquitin in a ubiquitin activating enzyme-dependent manner, a characteristic property of ubiquitin carrier proteins.Synonyms: E2-EPF5, E2EPF, OK/SW-cl.73, Ubiquitin carrier protein S, Ubiquitin-conjugating enzyme E2 S, Ubiquitin-conjugating enzyme E2-24 kDa, Ubiquitin-protein ligase S
-
Molekulargewicht
- 23845 Da
-
Gen-ID
- 27338, 9606
-
UniProt
- Q16763
-
Pathways
- Ubiquitin Proteasome Pathway
Target
-